XML 63 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
Financing
6 Months Ended
Jun. 30, 2014
Text Block [Abstract]  
Financing

(16) Financing

February 10, 2014 Follow-on Underwritten Public Offering

On February 10, 2014, the Company closed a follow-on underwritten public offering, in which it sold 7,867,438 shares of common stock at a price to the public of $4.00 per share and pre-funded warrants to purchase up to 2,158,750 shares of common stock at a price to the public of $3.99 per share for aggregate gross proceeds of $40.1 million. The pre-funded warrants have an exercise price of $0.01 per share and will expire if not exercised by February 10, 2021. The estimated net proceeds to the Company from the offering, after deducting underwriters’ discounts and commissions and other offering costs and expenses and excluding the proceeds of the exercise of the warrants, if any, were approximately $37.2 million.

May 7, 2013 Follow-on Underwritten Public Offering

On May 7, 2013, the Company closed a follow-on underwritten public offering, in which it sold 17,500,000 shares of common stock, together with matching warrants to purchase up to 17,500,000 shares of common stock, and pre-funded warrants to purchase up to 15,816,327 shares of common stock, together with matching warrants to purchase up to 15,816,327 shares of common stock, for aggregate gross proceeds of $16.5 million as follows:

 

    Combined Price
to the Public
(per share of
common
stock)
    Common
Stock
    Pre-funded
Warrants
    Matching
Warrants
 

Common stock and matching warrants sold (shares)

  $ 0.50        17,500,000        —          17,500,000   

Pre-funded warrants & matching warrants sold (shares)

  $ 0.49        —          15,816,327        15,816,327   
   

 

 

   

 

 

   

 

 

 

Total (shares)

      17,500,000        15,816,327        33,316,327   
   

 

 

   

 

 

   

 

 

 

Warrant exercise price (per share)

    —          —        $ 0.01      $ 0.47   

Term of warrant (years)

    —          —          7.0        5.0   

The net proceeds to the Company from the offering, after deducting underwriters’ discounts and commissions and offering costs and expenses and excluding the proceeds of the future exercise of the warrants, if any, were approximately $14.5 million.

The warrants and the pre-funded warrants each provide that, after the second anniversary of the date of issuance, the Company may redeem the warrants for $0.01 per share of common stock issuable on exercise of the warrants following 30 days’ prior written notice to the holder if the closing price of the common stock for 20 or more trading days in a period of 30 consecutive trading days is greater than or equal to $2.80.